Navigation Links
DURECT Corporation Announces Third Quarter 2013 Financial Results and Update of Programs
Date:11/4/2013

lure to maintain our collaborative agreements with third parties or consummate new collaborations and risks related to our (and our third party collaborators where applicable) difficulty or failure to obtain approvals from regulatory agencies with respect to our development activities and products, or ability to design, enroll, conduct and complete clinical trials, complete the design, development, and manufacturing process development of product candidates, manufacture and commercialize product candidates, obtain marketplace acceptance of product candidates, avoid infringing patents held by other parties and secure and defend patents of our own, and manage and obtain capital to fund operations and expenses. Further information regarding these and other risks is included in DURECT's Form 10-Q for the quarter ending June 30, 2013 under the heading "Risk Factors."DURECT CORPORATIONCONDENSED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (in thousands, except per share amounts)(unaudited)Three months ended

 September 30, Nine months ended

 September 30, 2013201220132012 Collaborative research and development and other revenue

$
358$
,126$
2,176$
41,681Product revenue, net

2,6082,7028,8618,127Total revenues

2,9663,82811,03749,808Operating expenses:Cost of product revenues 

1,1141,0373,8043,616Research and development

4,4734,74514,09515,361Selling, general and administrative 

3,0972,8549,2089,183Total operating expenses

8,6848,63627,10728,160Income (loss) from operations

(5,718)(4,808)(16,070)21,648Other income (expense):Interest and other income

7173466Interest and other expense

(313)(12)(316)(15)Net other income

(306)5(282)51Net Income (loss)

$
(6,024)$
(4,803)$  (16,352)$
21,699Net income (loss) per shareBasic 

$
(0.06)$
(0.05)$
(0.1
'/>"/>

SOURCE DURECT Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. DURECT Corporation Invites You to Join its Third Quarter 2013 Earnings Conference Call
2. DURECT Announces Changes to its Board of Directors
3. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
4. DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
5. DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference Call
6. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
7. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
8. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
9. DURECT to Participate in Upcoming Healthcare Conferences
10. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
11. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 An aggressive ... helped cut the rate of infection with a dangerous ... percent. Clostridium difficile, or C.diff, is a ... life-threatening inflammation of the colon. A recent article in ... Clostridium difficile Infection in the United States ...
(Date:2/27/2015)...   Synageva BioPharma Corp. (Synageva) (NASDAQ: ... therapeutic products for rare diseases, joins the National ... for Rare Diseases™ (EURORDIS™), The Global Genes Project™, ... Disease Day. On the last day ... other participants conduct special events to raise awareness ...
(Date:2/27/2015)... PLAINFIELD, N.J., Feb. 27, 2015  PTC Therapeutics, Inc. ... update and reported financial results for the fourth quarter ... "2014 was a transformative year for PTC. We ... delivering and developing RNA-targeted therapies in the rare disease ... PTC Therapeutics, Inc. "We are proud to bring the ...
Breaking Medicine Technology:Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11
... , THOUSAND OAKS, Calif., Nov. 30 Amgen ... present updated long-term safety and efficacy data for Nplate® (romiplostim) ... will present the first Nplate study in a pediatric setting ... the 2009 American Society of Hematology (ASH) Annual Meeting and ...
... , CHICAGO, Nov. 30 Middle-aged men and ... be unknowingly causing damage to their knees and increasing their ... the annual meeting of the Radiological Society of North America ... activity levels may be at greater risk for developing knee ...
Cached Medicine Technology:Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Too Much Physical Activity May Lead to Arthritis 2Too Much Physical Activity May Lead to Arthritis 3
(Date:3/1/2015)... Orion, Metamora, Michigan (PRWEB) March 01, 2015 ... is approved to treat Overactive Bladder (OAB) symptoms, such as ... in adults when another type of medication (anticholinergic) does not ... a different treatment option that takes another approach to targeting ... , BOTOX® works on the nerves and bladder muscle, blocking ...
(Date:3/1/2015)... Ticket Down is a reputable source for ... Soldier Field. Deadheads have been anxiously anticipating this blockbuster ... Dead was formed 50 years ago back in the 60s ... until the untimely death of Jerry Garcia in 1995. ... blues, reggae, rock, bluegrass, folk, space rock and country to ...
(Date:3/1/2015)... Aliso Viejo, California (PRWEB) March 01, 2015 ... have announced a new transition pack for ... users to add accordion style transitions to any FCPX ... Studios. “We’ve given our users the tools needed to ... FCPX media.” , The user gets many different controls ...
(Date:2/28/2015)... In a recent episode of ... Game Change Athlete Development Services and Consultancy talks ... of athlete development and player engagement during and after ... that athletes face and how off-field activities are a ... became involved in athlete development issues while in graduate ...
(Date:2/28/2015)... Morristown, NJ (PRWEB) February 28, 2015 ... Month—is a good time to remind ourselves and ... be ignored, say Atlantic NeuroSurgical Specialists (ANS). , ... (TBI), which account for 75% of TBIs. There ... word concussion may sound benign, but it is ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
... announced,the European launch of its i.v.STATION Robot with a ... Spain [Booth 21,Level -1] next week. Health Robotics also ... world, and the simultaneous showcase of,CytoCare(TM), the world,s only ... its strategic partners (B|Braun, Booths C9-C12). , ...
... CareBETHESDA, Md., March 18 The Cystic Fibrosis Foundation ... leadership in improving the quality of care for people ... Quality Assurance (NCQA).The outlook for people with CF continues ... by the Foundation. In the 1950s, few children with ...
... FRANCISCO, March 18 Medivation, Inc. (Nasdaq: ... received written permission from the U.S. Food and ... 3 trial of MDV3100, its novel androgen receptor ... (CRPC) who have failed docetaxel-based chemotherapy. The ...
... be applied using inkjet printer technology, researchers say , , ... partners as marine mussels and printer inkjet technology, researchers ... be used with greater precision, promote faster recovery and ... used to join tissue together after a patient has ...
... consumption offers the most protection, study finds, , , WEDNESDAY, March ... have one or two glasses of beer or wine a ... heavy drinkers, a new study suggests. , Moderate drinking has ... it also has been linked to increasing the risk for ...
... Taps into Latino Market Underserved by other ... Systems, Inc. (OTC Bulletin Board: FVRL), which ... (collectively, "MMR") provides consumer-controlled Personal Health Records ... deposit box storage solutions ( www.myesafedepositbox.com ), ...
Cached Medicine News:Health News:Health Robotics Announces European Launch of i.v.STATION(TM) and Global List of 2009 Installations 2Health News:Health Robotics Announces European Launch of i.v.STATION(TM) and Global List of 2009 Installations 3Health News:Health Robotics Announces European Launch of i.v.STATION(TM) and Global List of 2009 Installations 4Health News:Cystic Fibrosis Foundation to Receive Prestigious Health Care Award 2Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 2Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 3Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 4Health News:Mussel-Based Glue May Make Surgery Safer 2Health News:A Little Drink May Be Good for Your Bones 2Health News:A Little Drink May Be Good for Your Bones 3Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 2Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 3Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 4
... system introduces a new level ... microsurgical instrumentation. It has an ... with advanced microcomputer control of ... operate with a full range ...
... The Horizon Phacoemulsification System ... segment surgical system. Lightweight ... high-end performance and features ... It also provides all ...
Phaco-emulsification systems CV series...
Phacoemulsification system is a complete anterior segment surgical instrument. Its simplified design and unique innovations provide optimal surgical performance....
Medicine Products: